Category: Press Releases

Freiburg, May 7th, 2025 Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is currently no approved medicine to treat primary sclerosing cholangitis. The results of the 96-week analysis of the NUC-5 trial will be presented at 2025 EASL Congress in Amsterdam. Dr. Falk Pharma, a research-based pharmaceutical company specializing in digestive and metabolic medicine, today announced positive results from its pivotal, phase 3 trial (NUC-5) on norucholic acid (NCA) in primary sclerosing cholangitis (PSC). NUC-5 (NCT03872921) is a double-blind, placebo-controlled trial enrolling 301 patients with PSC, who receive either 1,500 mg NCA

AARHUS, Denmark, May 07, 2025 (GLOBE NEWSWIRE) — Arla Foods Ingredients will highlight the functional benefits of pure BLG (beta-lactoglobulin) in a new protein soda concept at Vitafoods Europe. Arla Foods Ingredients protein soda concept Arla Foods Ingredients protein soda concept Consumers are increasingly seeking functional beverages that support active, balanced lifestyles. According to the Innova Category Survey 2024, nearly 20% reduce their consumption of traditional carbonated drinks in the past year1. Arla Foods Ingredients’ protein soda concept is a tailored response to the “better-for-you” soft drink trend, providing 10g of protein per serving with zero sugar. It features Lacprodan® BLG-100

AARHUS, Denmark, May 07, 2025 (GLOBE NEWSWIRE) — Arla Foods Ingredients will highlight the functional benefits of pure BLG (beta-lactoglobulin) in a new protein soda concept at Vitafoods Europe. Arla Foods Ingredients protein soda concept Arla Foods Ingredients protein soda concept Consumers are increasingly seeking functional beverages that support active, balanced lifestyles. According to the Innova Category Survey 2024, nearly 20% reduce their consumption of traditional carbonated drinks in the past year1. Arla Foods Ingredients’ protein soda concept is a tailored response to the “better-for-you” soft drink trend, providing 10g of protein per serving with zero sugar. It features Lacprodan® BLG-100

SAN FRANCISCO, May 06, 2025 (GLOBE NEWSWIRE) — Meltwater, a global leader in media, social and consumer intelligence, today unveiled its latest innovations, led by the premiere of Mira, a game-changing AI teammate marking the next evolution in Meltwater’s AI-powered product suite. Combining the power of AI agents with GenAI, Mira delivers instant insights through an intuitive chat-based interface, streamlining time-consuming workflows such as news briefings, brand monitoring, competitive intelligence and much more. In today’s fragmented media landscape, brands struggle to keep up with the sheer volume of online conversations and stories. With a growing number of channels to monitor,

SAN FRANCISCO, May 06, 2025 (GLOBE NEWSWIRE) — Meltwater, a global leader in media, social and consumer intelligence, today unveiled its latest innovations, led by the premiere of Mira, a game-changing AI teammate marking the next evolution in Meltwater’s AI-powered product suite. Combining the power of AI agents with GenAI, Mira delivers instant insights through an intuitive chat-based interface, streamlining time-consuming workflows such as news briefings, brand monitoring, competitive intelligence and much more. In today’s fragmented media landscape, brands struggle to keep up with the sheer volume of online conversations and stories. With a growing number of channels to monitor,